"Leukemia, Myeloid, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
Concept/Terms
Leukemia, Myeloid, Acute- Leukemia, Myeloid, Acute
- ANLL
- Leukemia, Myeloblastic, Acute
- Leukemia, Myelocytic, Acute
- Leukemia, Myelogenous, Acute
- Nonlymphocytic Leukemia, Acute
- Acute Nonlymphocytic Leukemia
- Acute Nonlymphocytic Leukemias
- Leukemia, Acute Nonlymphocytic
- Leukemias, Acute Nonlymphocytic
- Nonlymphocytic Leukemias, Acute
- Leukemia, Nonlymphocytic, Acute
- Myeloblastic Leukemia, Acute
- Acute Myeloblastic Leukemia
- Acute Myeloblastic Leukemias
- Leukemia, Acute Myeloblastic
- Leukemias, Acute Myeloblastic
- Myeloblastic Leukemias, Acute
- Myelocytic Leukemia, Acute
- Acute Myelocytic Leukemia
- Acute Myelocytic Leukemias
- Leukemia, Acute Myelocytic
- Leukemias, Acute Myelocytic
- Myelocytic Leukemias, Acute
- Myelogenous Leukemia, Acute
- Acute Myelogenous Leukemia
- Acute Myelogenous Leukemias
- Leukemia, Acute Myelogenous
- Leukemias, Acute Myelogenous
- Myelogenous Leukemias, Acute
- Myeloid Leukemia, Acute
- Nonlymphoblastic Leukemia, Acute
- Acute Nonlymphoblastic Leukemia
- Acute Nonlymphoblastic Leukemias
- Leukemia, Acute Nonlymphoblastic
- Leukemias, Acute Nonlymphoblastic
- Nonlymphoblastic Leukemias, Acute
- Acute Myeloid Leukemia
- Acute Myeloid Leukemias
- Leukemia, Acute Myeloid
- Leukemias, Acute Myeloid
- Myeloid Leukemias, Acute
- Leukemia, Nonlymphoblastic, Acute
Below are MeSH descriptors whose meaning is more general than "Leukemia, Myeloid, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myeloid, Acute".
- Leukemia, Myeloid, Acute
- Leukemia, Basophilic, Acute
- Leukemia, Eosinophilic, Acute
- Leukemia, Erythroblastic, Acute
- Leukemia, Mast-Cell
- Leukemia, Megakaryoblastic, Acute
- Leukemia, Monocytic, Acute
- Leukemia, Promyelocytic, Acute
This graph shows the total number of publications written about "Leukemia, Myeloid, Acute" by people in Harvard Catalyst Profiles by year, and whether "Leukemia, Myeloid, Acute" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 6 | 3 | 9 |
1995 | 8 | 2 | 10 |
1996 | 4 | 1 | 5 |
1997 | 7 | 3 | 10 |
1998 | 4 | 0 | 4 |
1999 | 4 | 1 | 5 |
2000 | 7 | 1 | 8 |
2001 | 9 | 2 | 11 |
2002 | 11 | 2 | 13 |
2003 | 14 | 1 | 15 |
2004 | 10 | 3 | 13 |
2005 | 10 | 2 | 12 |
2006 | 15 | 2 | 17 |
2007 | 20 | 3 | 23 |
2008 | 26 | 12 | 38 |
2009 | 34 | 6 | 40 |
2010 | 57 | 9 | 66 |
2011 | 51 | 6 | 57 |
2012 | 63 | 7 | 70 |
2013 | 60 | 6 | 66 |
2014 | 68 | 8 | 76 |
2015 | 70 | 13 | 83 |
2016 | 96 | 14 | 110 |
2017 | 109 | 14 | 123 |
2018 | 112 | 14 | 126 |
2019 | 103 | 7 | 110 |
2020 | 117 | 3 | 120 |
2021 | 130 | 5 | 135 |
2022 | 129 | 1 | 130 |
2023 | 94 | 0 | 94 |
2024 | 27 | 0 | 27 |
Below are the most recent publications written about "Leukemia, Myeloid, Acute" by people in Profiles.
-
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML. Blood. 2024 Apr 11; 143(15):1513-1527.
-
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia. Blood Adv. 2024 Apr 09; 8(7):1621-1633.
-
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research. Cancer Med. 2024 Apr; 13(7):e6966.
-
Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes. Haematologica. 2024 Apr 01; 109(4):1289-1292.
-
Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect. Front Immunol. 2024; 15:1359113.
-
Cerebrospinal fluid concentrations of posaconazole in paediatric leukaemia patients. J Antimicrob Chemother. 2024 Mar 01; 79(3):564-566.
-
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study. Lancet Oncol. 2024 Mar; 25(3):388-399.
-
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome. Clin Transl Sci. 2024 Mar; 17(3):e13742.
-
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML. Blood Adv. 2024 Feb 27; 8(4):978-990.
-
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML. Leukemia. 2024 Apr; 38(4):762-768.